A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma
Clinical trial NCT05115292 · UNKNOWN
Trial details
- NCT number
- NCT05115292
- Sponsor
- BJ Bioscience, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2024-10-20
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.